Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR‐TKIs.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 754, doi. 10.1111/1759-7714.12646
- By:
- Publication type:
- Article
Works matching IS 17597706 AND DT 2018 AND VI 9 AND IP 6
Results: 13
1
2
Successful treatment with nivolumab for lung cancer with low expression of PD‐L1 and prominent tumor‐infiltrating B cells and immunoglobulin G.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 750, doi. 10.1111/1759-7714.12644
- By:
- Publication type:
- Article
3
Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 736, doi. 10.1111/1759-7714.12641
- By:
- Publication type:
- Article
4
Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 726, doi. 10.1111/1759-7714.12640
- By:
- Publication type:
- Article
5
Air bronchogram in pleomorphic carcinoma of the lung is associated with favorable prognosis.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 718, doi. 10.1111/1759-7714.12638
- By:
- Publication type:
- Article
6
Non‐small cell lung cancer harboring a rare EGFR L747P mutation showing intrinsic resistance to both gefitinib and osimertinib (AZD9291): A case report.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 745, doi. 10.1111/1759-7714.12637
- By:
- Publication type:
- Article
7
Present and changing trends in surgical modalities and neoadjuvant chemotherapy administration for female breast cancer in Beijing, China: A 10‐year (2006–2015) retrospective hospitalization summary report‐based study.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 707, doi. 10.1111/1759-7714.12636
- By:
- Publication type:
- Article
8
Image‐based management of empiric lung stereotactic body radiotherapy (SBRT) without biopsy: Predictors from a 10‐year single institution experience.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 699, doi. 10.1111/1759-7714.12635
- By:
- Publication type:
- Article
9
Molecular cross‐talk of IL‐6 in tumors and new progress in combined therapy.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 669, doi. 10.1111/1759-7714.12633
- By:
- Publication type:
- Article
10
Combination TS‐1 plus EGFR‐tyrosine kinase inhibitors (TKIs) for the treatment of non‐small cell lung cancer after progression on first‐line or further EGFR‐TKIs: A phase II, single‐arm trial.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 693, doi. 10.1111/1759-7714.12632
- By:
- Publication type:
- Article
11
Prognosis of multi‐level N2‐positive non‐small cell lung cancer according to lymph node staging using endobronchial ultrasound‐transbronchial biopsy.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 684, doi. 10.1111/1759-7714.12629
- By:
- Publication type:
- Article
12
Mir‐1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 676, doi. 10.1111/1759-7714.12607
- By:
- Publication type:
- Article
13
Issue Information.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 6, p. 667, doi. 10.1111/1759-7714.12516
- Publication type:
- Article